The Market Reports

Index

1 Home Insulin Delivery (Dosing) Devices Market Overview
1.1 Product Overview and Scope of Home Insulin Delivery (Dosing) Devices
1.2 Home Insulin Delivery (Dosing) Devices Segment by Type
1.2.1 Global Home Insulin Delivery (Dosing) Devices Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Insulin Pens
1.2.3 Insulin Pumps
1.2.4 Insulin Syringes
1.2.5 Others
1.3 Home Insulin Delivery (Dosing) Devices Segment by Application
1.3.1 Global Home Insulin Delivery (Dosing) Devices Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals Pharmacy
1.3.3 Online Pharmacy
1.3.4 Retail Pharmacy
1.4 Global Home Insulin Delivery (Dosing) Devices Market Size Estimates and Forecasts
1.4.1 Global Home Insulin Delivery (Dosing) Devices Revenue 2017-2028
1.4.2 Global Home Insulin Delivery (Dosing) Devices Sales 2017-2028
1.4.3 Home Insulin Delivery (Dosing) Devices Market Size by Region: 2017 Versus 2021 Versus 2028
2 Home Insulin Delivery (Dosing) Devices Market Competition by Manufacturers
2.1 Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Manufacturers (2017-2022)
2.2 Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Home Insulin Delivery (Dosing) Devices Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Home Insulin Delivery (Dosing) Devices Manufacturing Sites, Area Served, Product Type
2.5 Home Insulin Delivery (Dosing) Devices Market Competitive Situation and Trends
2.5.1 Home Insulin Delivery (Dosing) Devices Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Home Insulin Delivery (Dosing) Devices Players Market Share by Revenue
2.5.3 Global Home Insulin Delivery (Dosing) Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Home Insulin Delivery (Dosing) Devices Retrospective Market Scenario by Region
3.1 Global Home Insulin Delivery (Dosing) Devices Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Home Insulin Delivery (Dosing) Devices Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Home Insulin Delivery (Dosing) Devices Market Facts & Figures by Country
3.3.1 North America Home Insulin Delivery (Dosing) Devices Sales by Country
3.3.2 North America Home Insulin Delivery (Dosing) Devices Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Home Insulin Delivery (Dosing) Devices Market Facts & Figures by Country
3.4.1 Europe Home Insulin Delivery (Dosing) Devices Sales by Country
3.4.2 Europe Home Insulin Delivery (Dosing) Devices Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Home Insulin Delivery (Dosing) Devices Market Facts & Figures by Region
3.5.1 Asia Pacific Home Insulin Delivery (Dosing) Devices Sales by Region
3.5.2 Asia Pacific Home Insulin Delivery (Dosing) Devices Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Home Insulin Delivery (Dosing) Devices Market Facts & Figures by Country
3.6.1 Latin America Home Insulin Delivery (Dosing) Devices Sales by Country
3.6.2 Latin America Home Insulin Delivery (Dosing) Devices Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Home Insulin Delivery (Dosing) Devices Market Facts & Figures by Country
3.7.1 Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales by Country
3.7.2 Middle East and Africa Home Insulin Delivery (Dosing) Devices Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Home Insulin Delivery (Dosing) Devices Historic Market Analysis by Type
4.1 Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Type (2017-2022)
4.2 Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Type (2017-2022)
4.3 Global Home Insulin Delivery (Dosing) Devices Price by Type (2017-2022)
5 Global Home Insulin Delivery (Dosing) Devices Historic Market Analysis by Application
5.1 Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Application (2017-2022)
5.2 Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Application (2017-2022)
5.3 Global Home Insulin Delivery (Dosing) Devices Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Tandem Diabetes Care
6.1.1 Tandem Diabetes Care Corporation Information
6.1.2 Tandem Diabetes Care Description and Business Overview
6.1.3 Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Product Portfolio
6.1.5 Tandem Diabetes Care Recent Developments/Updates
6.2 Biocon
6.2.1 Biocon Corporation Information
6.2.2 Biocon Description and Business Overview
6.2.3 Biocon Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Biocon Home Insulin Delivery (Dosing) Devices Product Portfolio
6.2.5 Biocon Recent Developments/Updates
6.3 Roche Holding AG
6.3.1 Roche Holding AG Corporation Information
6.3.2 Roche Holding AG Description and Business Overview
6.3.3 Roche Holding AG Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Roche Holding AG Home Insulin Delivery (Dosing) Devices Product Portfolio
6.3.5 Roche Holding AG Recent Developments/Updates
6.4 Insulet Corporation
6.4.1 Insulet Corporation Corporation Information
6.4.2 Insulet Corporation Description and Business Overview
6.4.3 Insulet Corporation Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Insulet Corporation Home Insulin Delivery (Dosing) Devices Product Portfolio
6.4.5 Insulet Corporation Recent Developments/Updates
6.5 B. Braun
6.5.1 B. Braun Corporation Information
6.5.2 B. Braun Description and Business Overview
6.5.3 B. Braun Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.5.4 B. Braun Home Insulin Delivery (Dosing) Devices Product Portfolio
6.5.5 B. Braun Recent Developments/Updates
6.6 BD
6.6.1 BD Corporation Information
6.6.2 BD Description and Business Overview
6.6.3 BD Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.6.4 BD Home Insulin Delivery (Dosing) Devices Product Portfolio
6.6.5 BD Recent Developments/Updates
6.7 Eli Lilly and Company
6.6.1 Eli Lilly and Company Corporation Information
6.6.2 Eli Lilly and Company Description and Business Overview
6.6.3 Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Product Portfolio
6.7.5 Eli Lilly and Company Recent Developments/Updates
6.8 Novo Nordisk
6.8.1 Novo Nordisk Corporation Information
6.8.2 Novo Nordisk Description and Business Overview
6.8.3 Novo Nordisk Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Novo Nordisk Home Insulin Delivery (Dosing) Devices Product Portfolio
6.8.5 Novo Nordisk Recent Developments/Updates
6.9 Sanofi
6.9.1 Sanofi Corporation Information
6.9.2 Sanofi Description and Business Overview
6.9.3 Sanofi Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Sanofi Home Insulin Delivery (Dosing) Devices Product Portfolio
6.9.5 Sanofi Recent Developments/Updates
6.10 Wockhardt
6.10.1 Wockhardt Corporation Information
6.10.2 Wockhardt Description and Business Overview
6.10.3 Wockhardt Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Wockhardt Home Insulin Delivery (Dosing) Devices Product Portfolio
6.10.5 Wockhardt Recent Developments/Updates
6.11 Ypsomed Holding
6.11.1 Ypsomed Holding Corporation Information
6.11.2 Ypsomed Holding Home Insulin Delivery (Dosing) Devices Description and Business Overview
6.11.3 Ypsomed Holding Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Ypsomed Holding Home Insulin Delivery (Dosing) Devices Product Portfolio
6.11.5 Ypsomed Holding Recent Developments/Updates
6.12 Medtronic
6.12.1 Medtronic Corporation Information
6.12.2 Medtronic Home Insulin Delivery (Dosing) Devices Description and Business Overview
6.12.3 Medtronic Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Medtronic Home Insulin Delivery (Dosing) Devices Product Portfolio
6.12.5 Medtronic Recent Developments/Updates
6.13 Julphar
6.13.1 Julphar Corporation Information
6.13.2 Julphar Home Insulin Delivery (Dosing) Devices Description and Business Overview
6.13.3 Julphar Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Julphar Home Insulin Delivery (Dosing) Devices Product Portfolio
6.13.5 Julphar Recent Developments/Updates
6.14 Beta Bionics
6.14.1 Beta Bionics Corporation Information
6.14.2 Beta Bionics Home Insulin Delivery (Dosing) Devices Description and Business Overview
6.14.3 Beta Bionics Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Beta Bionics Home Insulin Delivery (Dosing) Devices Product Portfolio
6.14.5 Beta Bionics Recent Developments/Updates
6.15 Copernicus
6.15.1 Copernicus Corporation Information
6.15.2 Copernicus Home Insulin Delivery (Dosing) Devices Description and Business Overview
6.15.3 Copernicus Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Copernicus Home Insulin Delivery (Dosing) Devices Product Portfolio
6.15.5 Copernicus Recent Developments/Updates
6.16 Dance Biopharm
6.16.1 Dance Biopharm Corporation Information
6.16.2 Dance Biopharm Home Insulin Delivery (Dosing) Devices Description and Business Overview
6.16.3 Dance Biopharm Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Dance Biopharm Home Insulin Delivery (Dosing) Devices Product Portfolio
6.16.5 Dance Biopharm Recent Developments/Updates
6.17 Debiotech
6.17.1 Debiotech Corporation Information
6.17.2 Debiotech Home Insulin Delivery (Dosing) Devices Description and Business Overview
6.17.3 Debiotech Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Debiotech Home Insulin Delivery (Dosing) Devices Product Portfolio
6.17.5 Debiotech Recent Developments/Updates
6.18 MannKind
6.18.1 MannKind Corporation Information
6.18.2 MannKind Home Insulin Delivery (Dosing) Devices Description and Business Overview
6.18.3 MannKind Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.18.4 MannKind Home Insulin Delivery (Dosing) Devices Product Portfolio
6.18.5 MannKind Recent Developments/Updates
6.19 Owen Mumford
6.19.1 Owen Mumford Corporation Information
6.19.2 Owen Mumford Home Insulin Delivery (Dosing) Devices Description and Business Overview
6.19.3 Owen Mumford Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Owen Mumford Home Insulin Delivery (Dosing) Devices Product Portfolio
6.19.5 Owen Mumford Recent Developments/Updates
6.20 SOOIL
6.20.1 SOOIL Corporation Information
6.20.2 SOOIL Home Insulin Delivery (Dosing) Devices Description and Business Overview
6.20.3 SOOIL Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.20.4 SOOIL Home Insulin Delivery (Dosing) Devices Product Portfolio
6.20.5 SOOIL Recent Developments/Updates
6.21 Valeritas
6.21.1 Valeritas Corporation Information
6.21.2 Valeritas Home Insulin Delivery (Dosing) Devices Description and Business Overview
6.21.3 Valeritas Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.21.4 Valeritas Home Insulin Delivery (Dosing) Devices Product Portfolio
6.21.5 Valeritas Recent Developments/Updates
6.22 West Pharma
6.22.1 West Pharma Corporation Information
6.22.2 West Pharma Home Insulin Delivery (Dosing) Devices Description and Business Overview
6.22.3 West Pharma Home Insulin Delivery (Dosing) Devices Sales, Revenue and Gross Margin (2017-2022)
6.22.4 West Pharma Home Insulin Delivery (Dosing) Devices Product Portfolio
6.22.5 West Pharma Recent Developments/Updates
7 Home Insulin Delivery (Dosing) Devices Manufacturing Cost Analysis
7.1 Home Insulin Delivery (Dosing) Devices Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Home Insulin Delivery (Dosing) Devices
7.4 Home Insulin Delivery (Dosing) Devices Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Home Insulin Delivery (Dosing) Devices Distributors List
8.3 Home Insulin Delivery (Dosing) Devices Customers
9 Home Insulin Delivery (Dosing) Devices Market Dynamics
9.1 Home Insulin Delivery (Dosing) Devices Industry Trends
9.2 Home Insulin Delivery (Dosing) Devices Market Drivers
9.3 Home Insulin Delivery (Dosing) Devices Market Challenges
9.4 Home Insulin Delivery (Dosing) Devices Market Restraints
10 Global Market Forecast
10.1 Home Insulin Delivery (Dosing) Devices Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Home Insulin Delivery (Dosing) Devices by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Home Insulin Delivery (Dosing) Devices by Type (2023-2028)
10.2 Home Insulin Delivery (Dosing) Devices Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Home Insulin Delivery (Dosing) Devices by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Home Insulin Delivery (Dosing) Devices by Application (2023-2028)
10.3 Home Insulin Delivery (Dosing) Devices Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Home Insulin Delivery (Dosing) Devices by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Home Insulin Delivery (Dosing) Devices by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Home Insulin Delivery (Dosing) Devices Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Home Insulin Delivery (Dosing) Devices Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Home Insulin Delivery (Dosing) Devices Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Home Insulin Delivery (Dosing) Devices Market Competitive Situation by Manufacturers in 2021
Table 5. Global Home Insulin Delivery (Dosing) Devices Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Home Insulin Delivery (Dosing) Devices Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Home Insulin Delivery (Dosing) Devices Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Home Insulin Delivery (Dosing) Devices Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Home Insulin Delivery (Dosing) Devices Manufacturing Sites and Area Served
Table 11. Manufacturers Home Insulin Delivery (Dosing) Devices Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Home Insulin Delivery (Dosing) Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Home Insulin Delivery (Dosing) Devices as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Home Insulin Delivery (Dosing) Devices Sales by Region (2017-2022) & (K Units)
Table 16. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Region (2017-2022)
Table 17. Global Home Insulin Delivery (Dosing) Devices Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Region (2017-2022)
Table 19. North America Home Insulin Delivery (Dosing) Devices Sales by Country (2017-2022) & (K Units)
Table 20. North America Home Insulin Delivery (Dosing) Devices Sales Market Share by Country (2017-2022)
Table 21. North America Home Insulin Delivery (Dosing) Devices Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Home Insulin Delivery (Dosing) Devices Revenue Market Share by Country (2017-2022)
Table 23. Europe Home Insulin Delivery (Dosing) Devices Sales by Country (2017-2022) & (K Units)
Table 24. Europe Home Insulin Delivery (Dosing) Devices Sales Market Share by Country (2017-2022)
Table 25. Europe Home Insulin Delivery (Dosing) Devices Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Home Insulin Delivery (Dosing) Devices Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Home Insulin Delivery (Dosing) Devices Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Home Insulin Delivery (Dosing) Devices Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Home Insulin Delivery (Dosing) Devices Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Home Insulin Delivery (Dosing) Devices Revenue Market Share by Region (2017-2022)
Table 31. Latin America Home Insulin Delivery (Dosing) Devices Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Home Insulin Delivery (Dosing) Devices Sales Market Share by Country (2017-2022)
Table 33. Latin America Home Insulin Delivery (Dosing) Devices Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Home Insulin Delivery (Dosing) Devices Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Home Insulin Delivery (Dosing) Devices Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Home Insulin Delivery (Dosing) Devices Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Home Insulin Delivery (Dosing) Devices Revenue Market Share by Country (2017-2022)
Table 39. Global Home Insulin Delivery (Dosing) Devices Sales by Type (2017-2022) & (K Units)
Table 40. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Type (2017-2022)
Table 41. Global Home Insulin Delivery (Dosing) Devices Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Home Insulin Delivery (Dosing) Devices Revenue Share by Type (2017-2022)
Table 43. Global Home Insulin Delivery (Dosing) Devices Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Home Insulin Delivery (Dosing) Devices Sales (K Units) by Application (2017-2022)
Table 45. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Application (2017-2022)
Table 46. Global Home Insulin Delivery (Dosing) Devices Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Home Insulin Delivery (Dosing) Devices Revenue Share by Application (2017-2022)
Table 48. Global Home Insulin Delivery (Dosing) Devices Price by Application (2017-2022) & (US$/Unit)
Table 49. Tandem Diabetes Care Corporation Information
Table 50. Tandem Diabetes Care Description and Business Overview
Table 51. Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Tandem Diabetes Care Home Insulin Delivery (Dosing) Devices Product
Table 53. Tandem Diabetes Care Recent Developments/Updates
Table 54. Biocon Corporation Information
Table 55. Biocon Description and Business Overview
Table 56. Biocon Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Biocon Home Insulin Delivery (Dosing) Devices Product
Table 58. Biocon Recent Developments/Updates
Table 59. Roche Holding AG Corporation Information
Table 60. Roche Holding AG Description and Business Overview
Table 61. Roche Holding AG Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Roche Holding AG Home Insulin Delivery (Dosing) Devices Product
Table 63. Roche Holding AG Recent Developments/Updates
Table 64. Insulet Corporation Corporation Information
Table 65. Insulet Corporation Description and Business Overview
Table 66. Insulet Corporation Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Insulet Corporation Home Insulin Delivery (Dosing) Devices Product
Table 68. Insulet Corporation Recent Developments/Updates
Table 69. B. Braun Corporation Information
Table 70. B. Braun Description and Business Overview
Table 71. B. Braun Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. B. Braun Home Insulin Delivery (Dosing) Devices Product
Table 73. B. Braun Recent Developments/Updates
Table 74. BD Corporation Information
Table 75. BD Description and Business Overview
Table 76. BD Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. BD Home Insulin Delivery (Dosing) Devices Product
Table 78. BD Recent Developments/Updates
Table 79. Eli Lilly and Company Corporation Information
Table 80. Eli Lilly and Company Description and Business Overview
Table 81. Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Eli Lilly and Company Home Insulin Delivery (Dosing) Devices Product
Table 83. Eli Lilly and Company Recent Developments/Updates
Table 84. Novo Nordisk Corporation Information
Table 85. Novo Nordisk Description and Business Overview
Table 86. Novo Nordisk Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Novo Nordisk Home Insulin Delivery (Dosing) Devices Product
Table 88. Novo Nordisk Recent Developments/Updates
Table 89. Sanofi Corporation Information
Table 90. Sanofi Description and Business Overview
Table 91. Sanofi Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Sanofi Home Insulin Delivery (Dosing) Devices Product
Table 93. Sanofi Recent Developments/Updates
Table 94. Wockhardt Corporation Information
Table 95. Wockhardt Description and Business Overview
Table 96. Wockhardt Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Wockhardt Home Insulin Delivery (Dosing) Devices Product
Table 98. Wockhardt Recent Developments/Updates
Table 99. Ypsomed Holding Corporation Information
Table 100. Ypsomed Holding Description and Business Overview
Table 101. Ypsomed Holding Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Ypsomed Holding Home Insulin Delivery (Dosing) Devices Product
Table 103. Ypsomed Holding Recent Developments/Updates
Table 104. Medtronic Corporation Information
Table 105. Medtronic Description and Business Overview
Table 106. Medtronic Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. Medtronic Home Insulin Delivery (Dosing) Devices Product
Table 108. Medtronic Recent Developments/Updates
Table 109. Julphar Corporation Information
Table 110. Julphar Description and Business Overview
Table 111. Julphar Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. Julphar Home Insulin Delivery (Dosing) Devices Product
Table 113. Julphar Recent Developments/Updates
Table 114. Beta Bionics Corporation Information
Table 115. Beta Bionics Description and Business Overview
Table 116. Beta Bionics Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. Beta Bionics Home Insulin Delivery (Dosing) Devices Product
Table 118. Beta Bionics Recent Developments/Updates
Table 119. Copernicus Corporation Information
Table 120. Copernicus Description and Business Overview
Table 121. Copernicus Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. Copernicus Home Insulin Delivery (Dosing) Devices Product
Table 123. Copernicus Recent Developments/Updates
Table 124. Dance Biopharm Corporation Information
Table 125. Dance Biopharm Description and Business Overview
Table 126. Dance Biopharm Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 127. Dance Biopharm Home Insulin Delivery (Dosing) Devices Product
Table 128. Dance Biopharm Recent Developments/Updates
Table 129. Debiotech Corporation Information
Table 130. Debiotech Description and Business Overview
Table 131. Debiotech Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 132. Debiotech Home Insulin Delivery (Dosing) Devices Product
Table 133. Debiotech Recent Developments/Updates
Table 134. MannKind Corporation Information
Table 135. MannKind Description and Business Overview
Table 136. MannKind Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 137. MannKind Home Insulin Delivery (Dosing) Devices Product
Table 138. MannKind Recent Developments/Updates
Table 139. Owen Mumford Corporation Information
Table 140. Owen Mumford Description and Business Overview
Table 141. Owen Mumford Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 142. Owen Mumford Home Insulin Delivery (Dosing) Devices Product
Table 143. Owen Mumford Recent Developments/Updates
Table 144. SOOIL Corporation Information
Table 145. SOOIL Description and Business Overview
Table 146. SOOIL Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 147. SOOIL Home Insulin Delivery (Dosing) Devices Product
Table 148. SOOIL Recent Developments/Updates
Table 149. Valeritas Corporation Information
Table 150. Valeritas Description and Business Overview
Table 151. Valeritas Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 152. Valeritas Home Insulin Delivery (Dosing) Devices Product
Table 153. Valeritas Recent Developments/Updates
Table 154. West Pharma Corporation Information
Table 155. West Pharma Description and Business Overview
Table 156. West Pharma Home Insulin Delivery (Dosing) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 157. West Pharma Home Insulin Delivery (Dosing) Devices Product
Table 158. West Pharma Recent Developments/Updates
Table 159. Production Base and Market Concentration Rate of Raw Material
Table 160. Key Suppliers of Raw Materials
Table 161. Home Insulin Delivery (Dosing) Devices Distributors List
Table 162. Home Insulin Delivery (Dosing) Devices Customers List
Table 163. Home Insulin Delivery (Dosing) Devices Market Trends
Table 164. Home Insulin Delivery (Dosing) Devices Market Drivers
Table 165. Home Insulin Delivery (Dosing) Devices Market Challenges
Table 166. Home Insulin Delivery (Dosing) Devices Market Restraints
Table 167. Global Home Insulin Delivery (Dosing) Devices Sales Forecast by Type (2023-2028) & (K Units)
Table 168. Global Home Insulin Delivery (Dosing) Devices Sales Market Share Forecast by Type (2023-2028)
Table 169. Global Home Insulin Delivery (Dosing) Devices Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 170. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share Forecast by Type (2023-2028)
Table 171. Global Home Insulin Delivery (Dosing) Devices Sales Forecast by Application (2023-2028) & (K Units)
Table 172. Global Home Insulin Delivery (Dosing) Devices Sales Market Share Forecast by Application (2023-2028)
Table 173. Global Home Insulin Delivery (Dosing) Devices Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 174. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share Forecast by Application (2023-2028)
Table 175. Global Home Insulin Delivery (Dosing) Devices Sales Forecast by Region (2023-2028) & (K Units)
Table 176. Global Home Insulin Delivery (Dosing) Devices Sales Market Share Forecast by Region (2023-2028)
Table 177. Global Home Insulin Delivery (Dosing) Devices Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 178. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share Forecast by Region (2023-2028)
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Home Insulin Delivery (Dosing) Devices
Figure 2. Global Home Insulin Delivery (Dosing) Devices Market Share by Type in 2021 & 2028
Figure 3. Insulin Pens Product Picture
Figure 4. Insulin Pumps Product Picture
Figure 5. Insulin Syringes Product Picture
Figure 6. Others Product Picture
Figure 7. Global Home Insulin Delivery (Dosing) Devices Market Share by Application in 2021 & 2028
Figure 8. Hospitals Pharmacy
Figure 9. Online Pharmacy
Figure 10. Retail Pharmacy
Figure 11. Global Home Insulin Delivery (Dosing) Devices Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Home Insulin Delivery (Dosing) Devices Market Size (2017-2028) & (US$ Million)
Figure 13. Global Home Insulin Delivery (Dosing) Devices Sales (2017-2028) & (K Units)
Figure 14. Home Insulin Delivery (Dosing) Devices Sales Share by Manufacturers in 2021
Figure 15. Global Home Insulin Delivery (Dosing) Devices Revenue Share by Manufacturers in 2021
Figure 16. The Global 5 and 10 Largest Home Insulin Delivery (Dosing) Devices Players: Market Share by Revenue in 2021
Figure 17. Home Insulin Delivery (Dosing) Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Region (2017-2022)
Figure 19. Global Home Insulin Delivery (Dosing) Devices Sales Market Share by Region in 2021
Figure 20. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Region (2017-2022)
Figure 21. Global Home Insulin Delivery (Dosing) Devices Revenue Market Share by Region in 2021
Figure 22. United States Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Canada Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Germany Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. France Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. U.K. Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Italy Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Russia Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. China Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Japan Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. South Korea Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. India Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Australia Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. China Taiwan Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Indonesia Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Thailand Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Malaysia Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Mexico Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Brazil Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Argentina Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Colombia Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Turkey Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Saudi Arabia Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. UAE Home Insulin Delivery (Dosing) Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Sales Market Share of Home Insulin Delivery (Dosing) Devices by Type (2017-2022)
Figure 46. Manufacturing Cost Structure of Home Insulin Delivery (Dosing) Devices
Figure 47. Manufacturing Process Analysis of Home Insulin Delivery (Dosing) Devices
Figure 48. Home Insulin Delivery (Dosing) Devices Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed